Literature DB >> 23952893

Modeling the association between sexual maturation, transmissible risk, and peer relationships during childhood and adolescence on development of substance use disorder in young adulthood.

Michelle S Horner1, Ralph Tarter, Levent Kirisci, Duncan B Clark.   

Abstract

BACKGROUND: This prospective study investigated pubertal timing and transmissible risk in relation to affiliation with deviant peers on the development of substance use disorder (SUD).
METHOD: Participants were boys (N = 500) ascertained through proband fathers with (N = 250), and without (N = 250) DSM-III-R lifetime diagnosis of SUD who were prospectively tracked from age 10-12 to 22. Transmissible liability index (TLI), Tanner stage, peer delinquency, and substance use were measured at ages 10-12 and 16. SUD diagnosis during early adulthood was determined.
RESULTS: Structural equation modeling revealed two pathways in which transmissible risk and sexual maturation influenced development of SUD. In the first pathway, transmissible risk was correlated with and prospectively predicted affiliation with deviant peers and substance use presaging SUD. In the second pathway, advanced sexual maturation positively predicted affiliation with deviant peers and substance use, which in turn predicted SUD. However, transmissible risk was not associated with pubertal development.
CONCLUSION: These findings indicate that advanced sexual maturation and transmissible risk constitute unrelated facets of SUD liability; however, both factors bias development toward SUD via affiliation with deviant peers. SCIENTIFIC SIGNIFICANCE: Youth with advanced sexual maturation and/or transmissible risk for SUD are at higher risk for developing SUD. Additional research is needed to determine if addressing these risk factors will contribute to advancements in SUD prevention.
Copyright © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Year:  2013        PMID: 23952893      PMCID: PMC3915874          DOI: 10.1111/j.1521-0391.2013.12046.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  50 in total

1.  Genetic and environmental influences on substance initiation, use, and problem use in adolescents.

Authors:  Soo Hyun Rhee; John K Hewitt; Susan E Young; Robin P Corley; Thomas J Crowley; Michael C Stallings
Journal:  Arch Gen Psychiatry       Date:  2003-12

2.  Hanging out with the wrong crowd: how much difference can parents make in an urban environment?

Authors:  Jacqueline J Lloyd; James C Anthony
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

Review 3.  Liability to substance use disorders: 2. A measurement approach.

Authors:  Michael M Vanyukov; Levent Kirisci; Ralph E Tarter; Howard F Simkevitz; Galina P Kirillova; Brion S Maher; Duncan B Clark
Journal:  Neurosci Biobehav Rev       Date:  2003-10       Impact factor: 8.989

Review 4.  Liability to substance use disorders: 1. Common mechanisms and manifestations.

Authors:  Michael M Vanyukov; Ralph E Tarter; Levent Kirisci; Galina P Kirillova; Brion S Maher; Duncan B Clark
Journal:  Neurosci Biobehav Rev       Date:  2003-10       Impact factor: 8.989

5.  In emotional and cognitive development in the etiology of substance use disorders.

Authors:  Michelle S Horner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-04       Impact factor: 8.829

6.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Authors:  J B Williams; M Gibbon; M B First; R L Spitzer; M Davies; J Borus; M J Howes; J Kane; H G Pope; B Rounsaville
Journal:  Arch Gen Psychiatry       Date:  1992-08

7.  Biological maturation in adolescence and the development of drinking habits and alcohol abuse among young males: A prospective longitudinal study.

Authors:  T Andersson; D Magnusson
Journal:  J Youth Adolesc       Date:  1990-02

8.  Early puberty is associated with mental health problems in middle adolescence.

Authors:  Riittakerttu Kaltiala-Heino; Mauri Marttunen; Päivi Rantanen; Matti Rimpelä
Journal:  Soc Sci Med       Date:  2003-09       Impact factor: 4.634

9.  Measurement of the risk for substance use disorders: phenotypic and genetic analysis of an index of common liability.

Authors:  Michael M Vanyukov; Levent Kirisci; Lisa Moss; Ralph E Tarter; Maureen D Reynolds; Brion S Maher; Galina P Kirillova; Ty Ridenour; Duncan B Clark
Journal:  Behav Genet       Date:  2009-04-18       Impact factor: 2.805

Review 10.  Early-onset drug use and risk for drug dependence problems.

Authors:  Chuan-Yu Chen; Carla L Storr; James C Anthony
Journal:  Addict Behav       Date:  2008-11-01       Impact factor: 3.913

View more
  5 in total

1.  A new approach to researching the etiology of cannabis use disorder: integrating transmissible and nontransmissible risk within a developmental framework.

Authors:  Ralph Tarter; Levent Kirisci; Maureen Reynolds
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

2.  Temperament disturbances measured in infancy progress to substance use disorder 20 years later.

Authors:  Michelle S Horner; Maureen Reynolds; Betty Braxter; Levent Kirisci; Ralph E Tarter
Journal:  Pers Individ Dif       Date:  2015-08

3.  Which matters most? Demographic, neuropsychological, personality, and situational factors in long-term marijuana and alcohol trajectories for justice-involved male youth.

Authors:  Sarah W Feldstein Ewing; Francesca M Filbey; Thomas A Loughran; Laurie Chassin; Alex R Piquero
Journal:  Psychol Addict Behav       Date:  2015-06-01

4.  Quick screen to detect current substance use disorder in adolescents and the likelihood of future disorder.

Authors:  Levent Kirisci; Maureen Reynolds; Darin Carver; Ralph Tarter
Journal:  Drug Alcohol Depend       Date:  2012-09-19       Impact factor: 4.492

5.  Externalizing behavior and emotion dysregulation are indicators of transmissible risk for substance use disorder.

Authors:  Levent Kirisci; Ralph Tarter; Ty Ridenour; Maureen Reynolds; Michelle Horner; Michael Vanyukov
Journal:  Addict Behav       Date:  2014-10-31       Impact factor: 3.913

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.